However, as with any medication, there are a few things to consider
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, whereas semaglutide only targets the GLP-1 receptors
doi: 10.1007/s11154-023-09805-5
SA, SNP, and SA + SNP priming reversed the adverse effects of salinity stress on the AsA and glutathione pools, which was followed by a significant ( p 0.05) increase in the AsA and GSH values and a significant ( p 0.05) reduction in the DHA and GSSG contents ( Figures 3AD )
Diabetes 67(Supplement 1):522 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial